Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset Clostridioides difficile infection (HO-CDI) rates: A diagnostic stewardship intervention.

Autor: McCormick WL; Warren Alpert Medical School of Brown University, Providence, Rhode Island., Jackson G; Department of Infection Control, Newport Hospital, Newport, Rhode Island., Andrea SB; OHSU-PSU School of Public Health, Portland, Oregan.; Lifespan Biostatistics Epidemiology and Research Design Core, Rhode Island Hospital, Rhode Island., Whitehead V; Lifespan Clinical Microbiology Laboratory, Providence, Rhode Island., Chargualaf TL; Lifespan Clinical Microbiology Laboratory, Providence, Rhode Island., Touzard-Romo F; Division of Infectious Diseases, Alpert Medical School of Brown University, Providence, Rhode Island.; Department of Infection Control, Newport Hospital, Newport, Rhode Island.

Publikováno v: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 Jan; Vol. 45 (1), pp. 106-109. Date of Electronic Publication: 2023 Jul 10.

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study.

Autor: Rogers R; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Shehadeh F; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Mylona EK; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Rich J; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Neill M; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Touzard-Romo F; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Geffert S; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Larkin J; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Bailey JA; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Lu S; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Sweeney J; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA., Mylonakis E; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jul 01; Vol. 73 (1), pp. e208-e214.

Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.

Autor: Kalligeros M; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Shehadeh F; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Atalla E; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Mylona EK; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Aung S; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Pandita A; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Larkin J; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Sanchez M; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Touzard-Romo F; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA., Brotherton A; Clinical Pharmacy, Lifespan, Providence, RI, USA., Shah R; Clinical Pharmacy, Lifespan, Providence, RI, USA., Cunha CB; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA. Electronic address: ccunha@Lifespan.org., Mylonakis E; Infectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI, USA. Electronic address: emylonakis@lifespan.org.

Publikováno v: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2020 Sep; Vol. 22, pp. 842-844. Date of Electronic Publication: 2020 Aug 05.

Towards Understanding and Identification of Human Viral Co-Infections.

Autor: Wu, Hui^1,2,3 (AUTHOR) wuhui@stu.cpu.edu.cn, Zhou, Hang-Yu^2,3 (AUTHOR), Zheng, Heng¹ (AUTHOR) zhengh@cpu.edu.cn, Wu, Aiping^2,3 (AUTHOR) zhengh@cpu.edu.cn

Publikováno v: Viruses (1999-4915). May2024, Vol. 16 Issue 5, p673. 17p.

Renal and Metabolic Toxicities Following Initiation of HIV-1 Treatment Regimen in a Diverse, Multinational Setting: A Focused Safety Analysis of ACTG PEARLS (A5175).

Autor: Touzard Romo, F., Smeaton, L. M., Campbell, T. B., Riviere, C., Mngqibisa, R., Nyirenda, M., Supparatpinyo, K., Kumarasamy, N., Hakim, J. G., Flanigan, T. P.

Publikováno v: HIV Clinical Trials; Nov/Dec2014, Vol. 15 Issue 6, p246-260, 15p